XAIR - Beyond Air Inc logo

Beyond Air Inc

XAIR

Beyond Air develops the Lungfit platform, a nitric oxide generator for treating respiratory and neurological conditions. Its products include Lungfit PH for pulmonary hypertension and Lungfit PRO for viral lung infections, with ongoing clinical trials.

⚕️ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 10 years ago →$86today

Score Overview

1 Year
Score
Net Growth28.69%
Net TrendGrew
Net Income Consistency—
Rev Growth107.26%
Rev TrendGrew
Revenue Consistency—
5 Years
Score4.4
Net Growth-45.35%
Net Trend40%
Net Income Consistency—
Rev Growth8x
Rev Trend60%
Revenue Consistency—
All Time
Score—
Net Growth-84.27%
Net Trend38%
Net Income Consistency
Rev Growth—
Rev Trend50%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Beyond Air Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. XAIR does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 2.59—
1 Year2025-09-26
$ 49.20-94.74%
5 Years2021-09-28
$ 4.57K-99.94%
10 Years2016-09-27
$ 30.00-91.37%
All Time2017-09-22
$ 5.75-54.96%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
2026$ 7M-$ 33M$ 11M
2025$ 3M-$ 46M$ 6M
2024$ 1M-$ 60M$ 34M
2023$ 59K-$ 55M$ 45M
2022$ 145.19K-$ 43M$ 80M
2021$ 873K-$ 22M$ 34M
2020$ 1M-$ 19M$ 19M
2019$ 7M-$ 6M$ 7M
2018$ 0.00-$ 18M$ 9M
XAIR - Beyond Air Inc logo

Beyond Air Inc fundamental performance

Between 2021 and 2026, revenue grew from $ 873K to $ 7M and net income went from -$ 22M to -$ 33M. Revenue increased in 3 of those 5 years; net income in 2.

Beyond Air Inc currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.

Membership

Explore XAIR with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies